Product News and Articles

1 - 10 of 22 Articles 1 2 3 Next Next


Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
More »


Amplichek I Quality Control

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market
More »


Liquichek™ Maternal Serum II Control

Bio-Rad Announces the Release of Liquichek™ Maternal Serum II Control. The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results.
More »


Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

Researchers can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and viral infection.
More »


Bio-Rad Unveils Critical Raw Material Antigens for Diagnostic Uses

Bio-Rad announced the launch of human recombinant protein antigens, which expand the company’s critical raw material offering.
More »


New Lyphochek® Allergen sIgE Controls

Bio-Rad Releases New Lyphochek® Allergen sIgE Controls to Monitor Precision of In Vitro Allergy Test Procedures. Offering Cost Savings, Increased Efficiencies, and Less Waste
More »


Important Information for Bio-Rad Customers in North America: Business Systems Update

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1–July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.
More »


Bio-Rad and Inpeco Announce Agreement to Connect Bio-Rad Diagnostic Platforms to Inpeco’s Total Lab Automation System

Inpeco, a leading company in the field of laboratory automation, has entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms for diabetes, autoimmune disease, and infectious disease testing and Inpeco’s FlexLab™ 3.6 system.
More »


Bio-Rad and Axis-Shield Announce FDA Clearance and U.S. Launch of an Anti-CCP Test for Rheumatoid Arthritis for Bio-Rad's BioPlex 2200 System

The assay, which runs on Bio-Rad's BioPlex® 2200 system, measures anti-CCP, a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis.
More »


Bio-Rad Introduces its IH 1000, an Automated Blood Screening System

The IH 1000 is a fully-automated, high-throughput system designed for the blood transfusion laboratory utilizing the industry accepted gold standard ID-System gel card technology.
More »

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.